$26.10
3.49% today
Nasdaq, Apr 02, 09:20 pm CET
ISIN
US78349D1072
Symbol
RXST

RxSight Inc Stock price

$25.22
-1.71 6.35% 1M
-21.93 46.51% 6M
-9.16 26.64% YTD
-25.25 50.03% 1Y
+11.63 85.58% 3Y
+9.22 57.63% 5Y
+9.22 57.63% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-0.03 0.12%
ISIN
US78349D1072
Symbol
RXST
Sector

Key metrics

Market capitalization $1.02b
Enterprise Value $796.25m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.69
P/S ratio (TTM) P/S ratio 7.30
P/B ratio (TTM) P/B ratio 3.63
Revenue growth (TTM) Revenue growth 57.08%
Revenue (TTM) Revenue $139.93m
EBIT (operating result TTM) EBIT $-36.86m
Free Cash Flow (TTM) Free Cash Flow $-22.39m
Cash position $237.22m
EPS (TTM) EPS $-0.71
P/E forward negative
P/S forward 5.37
EV/Sales forward 4.19
Short interest 7.35%
Show more

Is RxSight Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

RxSight Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a RxSight Inc forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a RxSight Inc forecast:

Buy
80%
Hold
20%

Financial data from RxSight Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
140 140
57% 57%
100%
- Direct Costs 41 41
16% 16%
29%
99 99
84% 84%
71%
- Selling and Administrative Expenses 98 98
39% 39%
70%
- Research and Development Expense 34 34
18% 18%
25%
-33 -33
28% 28%
-24%
- Depreciation and Amortization 3.62 3.62
15% 15%
3%
EBIT (Operating Income) EBIT -37 -37
26% 26%
-26%
Net Profit -27 -27
44% 44%
-20%

In millions USD.

Don't miss a Thing! We will send you all news about RxSight Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RxSight Inc Stock News

Neutral
GlobeNewsWire
8 days ago
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 24th Annual Needham Virtual Healthcare Conference.
Neutral
Seeking Alpha
about one month ago
RxSight, Inc. (NASDAQ:RXST ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Oliver Moravcevic - VP, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference Call Participants Lily Lozada - JPMorgan Ryan Zimmerman - BTIG Steve Lichtman - Oppenheimer David Saxon - Needham Lei Huang - Wells Fargo Danielle Antalffy - UBS Thomas Stephan - Stifel Operator L...
Neutral
GlobeNewsWire
about one month ago
ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced financial results for the three months and full-year ended December 31, 2024.
More RxSight Inc News

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery The company was founded by Robert Grubbs and Daniel Schwartz on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Head office United States
CEO Ronald Kurtz
Employees 498
Founded 1997
Website rxsight.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today